Trial intelligence / Profile preview

ITOPS feasibility randomized trial in highly sensitized renal transplant candidates

2017-002602-12Phase 3Suspended

Sponsor

Cardiff and Vale University Health Board

Start

Dec 2017

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1